Illumina, Inc. and Solexa, Inc. have announced that they have entered into a definitive merger agreement under which Illumina will acquire Solexa in a stock-for-stock merger. Under the merger ...

Genome sequencing company Illumina Inc ILMN has transformed its business over the years with a handful of acquisitions and new product launches. An acquisition in 2006 was one of the most important in ...

Illumina Inc. said Monday it will buy Solexa Inc. for about $600 million. San Diego-based Illumina (NASDAQ:ILMN) is offering about $14 a share in its stock for every share of Hayward-based Solexa ...

Illumina, Inc. (Nasdaq:ILMN) today announced that, together with Solexa its wholly owned subsidiary, it has filed its initial response to the lawsuit brought by Life Technologies and Applied ...

Combination offers technology for genotyping, gene expression, and sequencing. Illumina will acquire Solexa in a stock-for-stock merger in a total equity consideration of approximately $600 million.

Shares in Hayward biotech company Solexa Inc. jumped almost 30 percent after it announced a $600 million stock-for-stock merger agreement Monday with Illumina Inc. of San Diego, another maker of ...

for $14 a share, or $600 million in stock, in a merger of genetic science players. The deal gives holders of Hayward, Calif.-based Solexa a 45% premium to Friday's closing price. San Diego-based ...

Illumina has agreed to buy Solexa, which makes genetics analysis systems, for $600 million. Illumina will also provide $50 million for Solexa, which specializes in whole genome sequencing. Illumina ...